Navigation Links
ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
Date:11/3/2009

CHICAGO, Nov. 3 /PRNewswire/ -- Advocate Lutheran General Hospital in the Chicago suburb of Park Ridge has chosen ScandiDos as the provider of its quality assurance (QA) solution for RapidArc(TM), and, in doing so, becomes the 100th clinical installation of Delta4. In selecting the Delta4 volumetric QA system, cancer care physicists and physicians at Advocate Lutheran General Hospital now have access to cutting edge verification of radiation therapy treatment. Key to this is the capability to perform real dose measurements and analyze the dose in the isocentric target region, the volume of greatest concern. The Delta4 system is in clinical use for IMRT, Arc therapy and TomoTherapy® since 2006 at clinics around the world.

As Advocate Lutheran General Hospital begins treating patients with RapidArc -- one form of volumetric modulated arc therapy (VMAT) or intensity modulated arc therapy (IMAT), having Delta4 for the pretreatment measurement and analysis of treatment plans will provide clinicians the comfort and confidence to proceed with these new, advanced treatments. Delta4's unique, advanced approach to measuring and presenting the dose data in three dimensions allows for quick, easy, and precise analysis of the treatment in relation to the prescription dose to the patient. Delta4's sophisticated analysis software allows the medical physicist to quickly analyze the measured dose against the treatment plan to determine the significance and cause of deviations in the dose. Because VMAT/IMAT modalities such as RapidArc by Varian Medical Systems employ many more treatment angles than conventional intensity modulated radiation therapy (IMRT), an integral part of the analysis of such is the delivery of dose from each of the actual gantry angles that will be delivered to the patient and the independent verification of each gantry angle as an element of the dose analysis. Delta4 is the only volumetric QA system on the market to perform th
'/>"/>

SOURCE ScandiDos
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
2. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use
5. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
6. GHX Health ConneXion(TM) Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009).... 1 Former New Jersey As...ed when his radiotherapy treatment sessions for pr...to less than five. Midway through his course of t...Cancer Center acquired the region,s first Rapid...ical Systems (NYSE: VAR ), making it possible fo...
(Date:12/1/2009)...Newswire/ -- The new position of Executive Vice Pr...logies, Inc. has been taken up by Howard Goldstein...0 years of experience creating and managing life s...irect Microchip Biotechnologies, marketing, busine...ons as the company makes the transition from produ...
(Date:12/1/2009)... Galenea Corp. and Otsuka Pharmaceu...ion of their research and development collaboratio...he collaboration term to seven years and brings th...lion. The companies have been working together si...developing first-in-class therapies for schizophre...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3UT School of Public Health researchers develop game for HIV+ youth 49792 1UT School of Public Health researchers develop game for HIV+ youth 49792 2Bycatch whaling a growing threat to coastal whales 8973 1Bycatch whaling a growing threat to coastal whales 8973 2Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2
...ncer diagnosis , , TAMPA, Fla., May 14 Moffitt...ve signed a license agreement on phospholipid biom...h has been granted exclusive worldwide rights to M...tiation, developmental milestone and license maint...rantz BioMarkers will collaborate on ovarian cance...
...poration (NYSE: BSX ) today announced data from ...al-word survival rates for implantable cardiac dev... ALTITUDE analyzes outcomes data from patients mo...em. Five-year survival rate data for patients usi...and cardiac resynchronization therapy defibrillato...
Other Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 2Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 3Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials 4
(Date:12/1/2009)... , , BELLEVUE, Wash., Dec 1 /PRNewswir...10 and Healthcare Channel Modernization solutions ...ranslator that facilitates HIPAA 4010A1 to HIPAA 5...-the-box 4010A1-5010 conversion maps, allows gener... between 4010A1 and 5010 in production, thus addre...
(Date:12/1/2009)... Highest rates seen in Central and South America,...Day News) -- About 50 percent of intensive care un...rease their risk of dying in the hospital, a new s...ed on a single day (May 8, 2007) on 13,796 patient...s. They found that 51 percent of patients were cla...
(Date:12/1/2009)... CDC urges H1N1 vaccination because pandemic,s co...Dec. 1 (HealthDay News) -- A U.S. health official ... to be on the wane nationally, but many experts ag...nter. , The flu is now widespread in 32 states ... R. Frieden, director of the U.S. Centers for Dise...
(Date:12/1/2009)... , Practitioners of any m...transcription are breathing a sigh of relief this ...e iPhone. The application, released over the holi... transcribe voice recordings to do so quickly and ... (PRWEB) December 1, 2009 -- T...
(Date:12/1/2009)... , , SMITHFIELD, R.I., D...otective equipment, bad assumptions are hazardous ... 25 years of government regulation, a handful of p...ering both the effectiveness of occupational Hear...aring. ,, A new free, white paper from Howard ...
Breaking Medicine News(10 mins):Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3
...helps identify cellular pathways involved in cance...y News) -- A protein called Lefty that regulates d...it the growth and spread of deadly melanomas and a...the Proceedings of the National Academy of Scienc...
...ICAGO --- A protein that governs development of hu... growth and spread of malignant melanoma, the dead...hers have discovered. Metastatic melanoma, which d...months. , The Northwestern scientists, led by r...
...Y, Wis., March 3 Shopko has some groundbreaking,n... bringing a fifth Shopko,store to Iowa as well as ...ill be the first Shopko store in Council Bluffs., ...ko stores. The new store in Council Bluffs will fe...
...NGELES (EMBARGOED UNTIL MARCH 3, 2008, AT 5 P.M. E...nstitute, Johns Hopkins University and China Medic...d for the first time the mechanisms by which varia...playing a role in heart function. , The study, co...
...it comes to a diagnosis of Alzheimer,s disease, wh...e truth as soon as possible appears to be the bett...ll-being of both patients and their caregivers, su...a 2004 review of research found about half of all ...
...N, Mass., March 3 Indevus,Pharmaceuticals, Inc. (...er,M.D. plans to retire as Indevus, Chief Executiv...ater this year on or prior to September 1, 2008., ...ny. Over the years, we have successfully developed...
Other Medicine News:Health News:Embryonic Stem Cell Protein Inhibits Melanoma 2Health News:Protein in embryonic stem cells control malignant tumor cells 2Health News:Protein in embryonic stem cells control malignant tumor cells 3Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Researchers describe mechanisms by which capon gene causes heart rhythm disturbances 2Health News:Dementia diagnosis brings relief, not depression 2Health News:Dementia diagnosis brings relief, not depression 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3
Freedom® Twist Drainage Port Leg Bags
Hydrophilic Personal Catheter Closed System-Kit
Freedom® Flocked Back Fas-Tap&trade Drainage Port Leg Bags
Antibacterial Hydro Personal Catheter Closed System-Kit
Medicine Products: